1. Home
  2. EYPT vs SMC Comparison

EYPT vs SMC Comparison

Compare EYPT & SMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • SMC
  • Stock Information
  • Founded
  • EYPT 1987
  • SMC 2009
  • Country
  • EYPT United States
  • SMC United States
  • Employees
  • EYPT N/A
  • SMC N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • SMC
  • Sector
  • EYPT Industrials
  • SMC
  • Exchange
  • EYPT Nasdaq
  • SMC NYSE
  • Market Cap
  • EYPT 489.4M
  • SMC 402.7M
  • IPO Year
  • EYPT 2005
  • SMC 2012
  • Fundamental
  • Price
  • EYPT $6.15
  • SMC $43.35
  • Analyst Decision
  • EYPT Strong Buy
  • SMC
  • Analyst Count
  • EYPT 8
  • SMC 0
  • Target Price
  • EYPT $25.71
  • SMC N/A
  • AVG Volume (30 Days)
  • EYPT 886.1K
  • SMC 68.6K
  • Earning Date
  • EYPT 03-06-2025
  • SMC 03-04-2025
  • Dividend Yield
  • EYPT N/A
  • SMC N/A
  • EPS Growth
  • EYPT N/A
  • SMC N/A
  • EPS
  • EYPT N/A
  • SMC N/A
  • Revenue
  • EYPT $45,713,000.00
  • SMC $450,857,000.00
  • Revenue This Year
  • EYPT N/A
  • SMC N/A
  • Revenue Next Year
  • EYPT N/A
  • SMC N/A
  • P/E Ratio
  • EYPT N/A
  • SMC N/A
  • Revenue Growth
  • EYPT 7.50
  • SMC 7.80
  • 52 Week Low
  • EYPT $5.90
  • SMC $17.26
  • 52 Week High
  • EYPT $29.31
  • SMC $45.89
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 36.22
  • SMC 55.11
  • Support Level
  • EYPT $5.90
  • SMC $43.10
  • Resistance Level
  • EYPT $6.67
  • SMC $45.38
  • Average True Range (ATR)
  • EYPT 0.71
  • SMC 1.59
  • MACD
  • EYPT -0.04
  • SMC -0.08
  • Stochastic Oscillator
  • EYPT 8.99
  • SMC 51.15

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About SMC SUMMIT MIDSTREAM CORPORATION

Summit Midstream Corp is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets strategically located in unconventional resource basins, primarily shale formations, in the continental U.S. It currently operates natural gas, crude oil and produced water gathering systems in four unconventional resource basins: the Williston Basin in North Dakota, which includes the Bakken and Three Forks shale formations; the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; the Fort Worth Basin in Texas, which includes the Barnett Shale formation; and the Piceance Basin in Colorado, which includes the liquids-rich Mesaverde formation as well as the emerging Mancos and Niobrara Shale formations.

Share on Social Networks: